Ethylene Glycol Induced Hyperoxaluria Increases Plasma and Renal Tissue Asymmetrical Dimethylarginine in Rats: A New Pathogenetic Link in Hyperoxaluria Induced Disorders

Journal of Urology

Volumn 183, Issue 2, 2010, Pages 759-764

  Aydin, Hasan ^a   Yencilek, Faruk ^a   Mutlu, Nilgün ^a   Çomunoǧlu, Nil ^a   Koyuncu, Hasbey Hakan ^a   Sarica, Kemal ^a  

^a YEDITEPE UNIVERSITY   (Turkey)

Author keywords

dimethylarginine; endothelium; hyperoxaluria; kidney; kidney calculi

Indexed keywords

ETHYLENE GLYCOL; N(G),N(G) DIMETHYLARGININE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FOLLOW UP; HISTOPATHOLOGY; HYPEROXALURIA; KIDNEY PARENCHYMA; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARGININE; ETHYLENE GLYCOL; HYPEROXALURIA; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; VERAPAMIL;

EID: 73749088033     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.09.076     Document Type: Article

References (29)

1. Ramello A., Vitale C., and Marangella M. Epidemiology of nephrolithiasis. J Nephrol 13 suppl. (2000) S45
2. Khan S.R. Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Exp Nephrol 98 (2004) 55
3. Green M.L., Freel R.W., and Hatch M. Lipid peroxidation is not the underlying cause of renal injury in hyperoxaluric rats. Kidney Int 68 (2005) 2629
4. Hackett R.L., Shevock P.N., and Khan S.R. Cell injury associated calcium oxalate crystalluria. J Urol 144 (1990) 1535
5. Thamilselvan S., Khan S.R., and Menon M. Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31 (2003) 3
6. Linas S.L., and Repine J.E. Endothelial cells regulate proximal tubule epithelial cell sodium transport. Kidney Int 55 (1999) 1251
7. Gobe G.C., and Johnson D.W. Distal tubular epithelial cells of the kidney: potential support for proximal tubular cell survival after renal injury. Int J Biochem Cell Biol 39 (2007) 1551
8. Böger R.H., Bode-Böger S.M., Szuba A., et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98 (1998) 1842
9. Tojo A., Welch W.J., and Bremer V. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney. Kidney Int 52 (1997) 1593
10. McLay J.S., Chatterjee P., Nicolson A.G., et al. Nitric oxide production by human proximal tubular cells: a novel immunomodulatory mechanism?. Kidney Int 46 (1994) 1043
11. Verkoelen C.F., and van derBoom B.G. Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture. Am J Physiol 274 (1998) F958
12. Khan S.R. Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8 (2004) 75
13. Khan S.R., and Kok D.J. Modulators of urinary stone formation. Front Biosci 9 (2004) 1450
14. Sarica K., Yagci F., Bakir K., et al. Renal tubular injury induced by hyperoxaluria: evaluation of apoptotic changes. Urol Res 29 (2001) 34
15. Tsujihata M. Mechanism of calcium oxalate renal stone formation and renal tubular cell injury. Int J Urol 15 (2008) 115
16. Iguchi M., Ikegami M., Kiwamoto H., et al. Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers. Hinyokika Kiyo 39 (1993) 425
17. Sarica K., Erturhan S., and Altay B. Effect of verapamil on urinary stone-forming risk factors. Urol Res 35 (2007) 23
18. Kedziora-Kornatowska K., Szram S., Kornatowski T., et al. The effect of verapamil on the antioxidant defence system in diabetic kidney. Clin Chim Acta 322 (2002) 105
19. Lüscher T.F., and Yang Z. Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle. Drugs 46 suppl. (1993) 121
20. Fishbein G.A., Micheletti R.G., Currier J.S., et al. Atherosclerotic oxalosis in coronary arteries. Cardiovasc Pathol 17 (2008) 117
21. Recht P.A., Tepedino G.J., Siecke N.W., et al. Oxalic acid alters intracellular calcium in endothelial cells. Atherosclerosis 173 (2004) 321
22. Levin R.I., Kantoff P.W., and Jaffe E.A. Uremic levels of oxalic acid suppress replication and migration of human endothelial cells. Arteriosclerosis 10 (1990) 198
23. Falasca G.F., Ramachandrula A., Kelley K.A., et al. Superoxide anion production and phagocytosis of crystals by cultured endothelial cells. Arthritis Rheum 36 (1993) 105
24. Zoccali C. Asymmetric dimethylarginine in end-stage renal disease patients: a biomarker modifiable by calcium blockade and angiotensin II antagonism?. Kidney Int 70 (2006) 2053
25. Sakhaee K. Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 17 (2008) 304
26. Asplin J.R. Obesity and urolithiasis. Adv Chronic Kidney Dis 16 (2009) 11
27. Laminski N.A., Meyers A.M., Kruger M., et al. Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors. Br J Urol 68 (1991) 454
28. Sarica K., Altay B., and Erturhan S. Effect of being overweight on stone-forming risk factors. Urology 71 (2008) 771
29. Khan S.R., Glenton P.A., and Byer K.J. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline. Kidney Int 70 (2006) 914